Post-stroke Pathway: Analysis and Link With One Year Sequelae in a French Cohort of Stroke Patients

NCT ID: NCT03865173

Last Updated: 2022-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1138 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-18

Study Completion Date

2022-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The link between post-stroke pathways and patient sequelae have not yet been clearly defined. The main purpose is to identify the post-stroke life pathways components associated with sequalae at 3 months and 1 year after the acute stroke episode.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Stroke is a serious health event, involving the entire health care system and generating considerable socioeconomic weight for society. Knowledge of the components, the diversity and the scalability of post-stroke life pathways is currently not sufficient. Moreover the link between post-stroke pathways and patient sequelae have not yet been clearly defined.

The main purpose is to identify the post-stroke life pathways components associated with sequalae at 3 months and 1 year after the acute stroke episode. The secondary objectives are: 1) To define a typology of the life pathways of stroke patients, , 2) To analyze the social and geographical inequalities in the management of stroke, 4) To estimate the cost of the pathway elements of stroke management; 5) Measure the sequelae of stroke patients at three months and one year after the acute episode.

The design is a prospective multicenter cohort study with a follow up to 1 year after the acute episode, managed in several hospitals in the Aquitaine region (France).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Stroke Sequelae

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telephone Interview

Telephone Interview

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient being over 18 years of age living in metropolitan France;
* Patient with recent stroke (not before 2019) whose diagnosis confirmed by a neuro-vascular physician;
* Patient managed for stroke in one of the 13 participating hospitals of the Aquitaine region;
* Patient giving consent to participate to PAPASéPA;
* Patient to be alive at the end of the acute management hospital stay

Exclusion Criteria

* Patient refuse to participate to PAPASéPA
* Patient died during the initial stay
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH Agen

Agen, , France

Site Status

CH Blaye

Blaye, , France

Site Status

CHU Bordeaux

Bordeaux, , France

Site Status

CH Arcachon

La Teste-de-Buch, , France

Site Status

CH Sud Gironde - Langon

Langon, , France

Site Status

Clinique Mutualiste Lesparre Médoc

Lesparre-Médoc, , France

Site Status

CH Libourne

Libourne, , France

Site Status

CHIC Marmande-Tonneins

Marmande, , France

Site Status

CH Mont de Marsan - site Layné

Mont-de-Marsan, , France

Site Status

CH Oloron

Oloron-Sainte-Marie, , France

Site Status

CH Orthez

Orthez, , France

Site Status

CH Pau

Pau, , France

Site Status

Pôle de Santé du Villeneuvois

Villeneuve-sur-Lot, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Broussy S, Rouanet F, Lesaine E, Domecq S, Kret M, Maugeais M, Aly F, Dehail P, Benard A, Wittwer J, Salamon R, Sibon I, Saillour-Glenisson F. Post-stroke pathway analysis and link with one year sequelae in a French cohort of stroke patients: the PAPASePA protocol study. BMC Health Serv Res. 2019 Oct 29;19(1):770. doi: 10.1186/s12913-019-4522-2.

Reference Type DERIVED
PMID: 31665006 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2016/30

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.